Zyprexa May Be Helped By Study On Discontinuations Of Antipsychotics, Lilly Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Study funded by NIH is examining all-cause treatment discontinuations for products in the class, with results expected to be published in the summer. Lilly hopes that results will highlight Zyprexa's efficacy and place side effects concerns in context.